Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
-
Published:2019-02-11
Issue:5
Volume:68
Page:773-785
-
ISSN:0340-7004
-
Container-title:Cancer Immunology, Immunotherapy
-
language:en
-
Short-container-title:Cancer Immunol Immunother
Author:
Nguyen Linh T.ORCID, Saibil Samuel D., Sotov Valentin, Le Michael X., Khoja Leila, Ghazarian Danny, Bonilla Luisa, Majeed Habeeb, Hogg David, Joshua Anthony M., Crump Michael, Franke Norman, Spreafico Anna, Hansen Aaron, Al-Habeeb Ayman, Leong Wey, Easson Alexandra, Reedijk Michael, Goldstein David P., McCready David, Yasufuku Kazuhiro, Waddell Thomas, Cypel Marcelo, Pierre Andrew, Zhang Bianzheng, Boross-Harmer Sarah, Cipollone Jane, Nelles Megan, Scheid Elizabeth, Fyrsta Michael, Lo Charlotte S., Nie Jessica, Yam Jennifer Y., Yen Pei Hua, Gray Diana, Motta Vinicius, Elford Alisha R., DeLuca Stephanie, Wang Lisa, Effendi Stephanie, Ellenchery Ragitha, Hirano Naoto, Ohashi Pamela S., Butler Marcus O.ORCID
Funder
Princess Margaret Cancer Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference31 articles.
1. Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348(6230):62–68.
https://doi.org/10.1126/science.aaa4967 2. Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17(13):4550–4557.
https://doi.org/10.1158/1078-0432.CCR-11-0116 3. Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P (2012) Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24):6758–6770.
https://doi.org/10.1158/1078-0432.CCR-12-1177 4. Pilon-Thomas S, Kuhn L, Ellwanger S, Janssen W, Royster E, Marzban S, Kudchadkar R, Zager J, Gibney G, Sondak VK, Weber J, Mule JJ, Sarnaik AA (2012) Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma. J Immunother 35(8):615–620.
https://doi.org/10.1097/CJI.0b013e31826e8f5f 5. Besser MJ, Shapira-Frommer R, Itzhaki O, Treves AJ, Zippel DB, Levy D, Kubi A, Shoshani N, Zikich D, Ohayon Y, Ohayon D, Shalmon B, Markel G, Yerushalmi R, Apter S, Ben-Nun A, Ben-Ami E, Shimoni A, Nagler A, Schachter J (2013) Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies. Clin Cancer Res 19(17):4792–4800.
https://doi.org/10.1158/1078-0432.CCR-13-0380
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|